Teradyne 10-Qquarter ended 2026-09-27

Positive

AI demand drove record memory-test sales; planned FormFactor stake targets silicon photonics and high-bandwidth memory.

Filed 2026-10-30 13:00 ET

Key figures · Q3 FY2026 · period ended 2026-09-27

  • Revenue$1.3BYoY +69.8%QoQ −1.7%
  • Operating income$402.0MYoY +176.6%QoQ −8.2%
  • Net income$342.4MYoY +186.4%QoQ −8.6%
  • Total assets$5.4BYoY +37.5%QoQ +10.6%
  • Total debt$0Previous quarter $0
  • Shareholders' equity$3.7BQoQ +7.3%
  • Tangible book value$2.9BQoQ +9.6%
Notes on other figures in this summary (1)
  • Cash and cash equivalents: Summary: $625M · Filing: $460.7M

    Comment from AI: The summary's $625M is cash and marketable securities combined; cash and cash equivalents of $460.7M excludes marketable securities.

How this filing reads

  • Health+0.4Nine-month operating cash flow was $1.05B; $1B capacity supplements $625M cash against $1.91B near-term commitments.
  • Momentum+0.8Q3 revenue rose 70%, operating income 177%, and net income 186% year over year.
  • Outlook+0.5AI demand remains strong; Semiconductor Test exceeded $1B in each of three consecutive quarters.

Executive Summary

Teradyne sells semiconductor and electronics test equipment, industrial robots and related services to chipmakers, electronics manufacturers and automation customers. It is expanding its testing capabilities for AI computing, memory and data-center connections through internal development, acquisitions and partnerships. Q3 showed strong demand translating into substantially higher profits, although semiconductor-test growth slowed from its nine-month pace. The opportunity is broader testing demand across AI infrastructure; the threat is concentrated customer spending and substantial supplier commitments that could become burdensome if demand weakens.

What's Happening in the Business

AI-related compute and memory demand remained the main engine. Semiconductor Test exceeded $1B in quarterly revenue for the third consecutive quarter, while memory-test revenue reached a record $301M, its fourth consecutive quarter above $200M. This sustained strength supports Teradyne’s investment in test development, but quarterly growth is moderating against the nine-month pace.

Teradyne is extending its reach beyond chip testing into AI infrastructure connections. April’s acquisition of a controlling 75% interest in MultiLane Test Products for $158M added high-speed interconnect testing to Product Test. That segment also benefited from board test, optical, Wireless, and Defense and Aerospace demand.

After quarter-end, Teradyne agreed to invest $300M for a non-controlling minority stake in FormFactor. The planned collaboration covers silicon photonics, high-performance computing, advanced packaging and high-bandwidth memory; closing was expected in Q4, subject to approvals and conditions. Management also expects continued R&D investment, particularly in 2027.

Robotics reached record third-quarter revenue as electronics and semiconductor customers expanded purchases. Higher volume, better product mix and lower operating expenses following restructuring brought it just above break-even, suggesting the recovery is reaching profitability rather than merely rebuilding sales.

Key Financial Highlights

Q3 and nine months ended 9/27/2026; changes are Y/Y.

Metric Q3 2026 9M 2026 Investor interpretation
Revenue $1.31B; +70% $3.92B; +86% Semiconductor equipment drove growth, but the quarter grew more slowly than the nine-month period.
Operating income $402M; +177% $1.31B; +268% Favorable product mix and revenue growth spread development and administrative costs over a larger sales base.
Net income $342M; +186% $1.12B; +276% Operating gains drove earnings; a lower quarterly tax rate provided an additional lift.

Segment profit is income before taxes and equity earnings.

Segment Q3 revenue; Y/Y 9M revenue; Y/Y Q3 profit; Y/Y 9M profit; Y/Y
Semiconductor Test $1.07B; +77% $3.31B; +102% $367M; +143% $1.26B; +214%
Product Test $138M; +56% $326M; +32% $41.4M; +161% $64.1M; +60%
Robotics $95.8M; +28% $287M; +31% $0.345M vs $(17.6)M $(3.20)M vs $(73.3)M
  • Revenue mix: Product revenue reached $1.16B, +84%, while services grew 3.4% to $142M; growth depended primarily on equipment purchases rather than recurring support.
  • Margins and investment: Q3 gross margin reached 59.1%, up 70 bp. Engineering and development expense increased 31% to $163M, reflecting strategic Semiconductor Test investment, but sales growth more than absorbed that spending.
  • Cash generation: 9M OCF was $1.05B, +167%, against net income shown above. Working capital absorbed $218M versus $48.6M previously as receivables, inventory and supplier-related prepayments increased; higher payables partly offset those uses. Capital spending rose 50% to $242M, leaving FCF of $806M.
  • Liquidity and commitments: Cash and marketable securities totaled $625M, with no revolving borrowings and $1B of facility capacity. Purchase commitments totaled $2.25B, including $1.91B due within one year—1.82 times nine-month OCF—and supplier prepayments reached $540M, +48%. These are procurement obligations, not contracted future revenue.
  • Capital returns: Nine-month repurchases fell to $174M from $519M; dividends totaled $61.0M. Shares outstanding were broadly unchanged from year-end, so buybacks did not meaningfully shrink the share base.

Risk Assessment

  • Customer concentration: Semiconductor-test demand depends on a limited number of customers and their supply partners, making order delays or spending cuts consequential.
  • Supply commitments: Large near-term purchase obligations and growing supplier prepayments expose Teradyne to excess inventory and cash absorption if AI-related demand slows.
  • Trade restrictions: Export controls, sanctions and tariffs could restrict sales or disrupt supply chains, with Asia Pacific accounting for ≈86% of Q3 revenue.

This 10-Q lists no risk factors of its own and refers to the annual report. The risks above come from the rest of this filing. Full list: the company's 10-Ks on SEC.

What to Watch

  • Semiconductor-test durability: Memory revenue is at a record and the segment has sustained three quarters above $1B; continued strength would support the AI opportunity, while order weakness would challenge the capacity commitment.
  • Robotics profitability: Q3 barely cleared break-even; sustained profits alongside customer growth would validate restructuring, while renewed losses would question its durability.
  • Expanded AI testing: Watch MultiLane’s contribution and the pending FormFactor investment; commercial adoption would validate the broader offering, while delays or impairments would weaken the case.
  • Cash funding: Watch whether collections catch up with inventory and prepayments as supplier commitments and the planned investment consume cash; stronger conversion would preserve flexibility, while renewed borrowing would show greater funding pressure.

Longer version: the summary of each of the report's 6 sections, written by an AI model from the same filing.

Changes since the previous 10-Q

Since the Q2 FY2026 10-Q:

The core bet (strengthened): Expand testing across AI chips, memory and connections as infrastructure customers sustain spending. → Compute demand persisted; memory testing reached $301M, extending its run above $200M.

  1. Risk removed Credit-facility expiry
    The $750M revolver expired December 10; management intended to seek an extension. → August’s five-year $1B revolver removed the approaching expiry risk.
  2. Risk escalated Near-term purchase commitments
    $1.56B of purchase commitments fell due within one year, increasing demand-reversal exposure. → One-year commitments reached $1.91B, increasing exposure if AI demand weakens.

Was this summary useful?

Figures are computed from the filing's XBRL data; the summary and scores are written by an AI model reading the filing.

Model 006 · prompt v163 · 2026-10-30 22:40:09Z

Feedback